Icíar Avilés-Olmos

机构：Magna Graecia University, Navarre Institute of Health Research, Clinica Universidad de Navarra, Universidad de Navarra, Chartered Institute of Management Accountants · ORCID：0000-0002-1645-7406

发表论文 65 篇 · 总被引 4182 次 · h-index 25

代表论文

• Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial (2017 · The Lancet · 被引 884)
• Differences in MDS ‐ UPDRS Scores Based on Hoehn and Yahr Stage and Disease Duration (2017 · Movement Disorders Clinical Practice · 被引 145)
• A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease (2016 · Science Translational Medicine · 被引 119)
• Time to Consider the “Exposome Hypothesis” in the Development of the Obesity Pandemic (2022 · Nutrients · 被引 93)
• Relationship between the MDS-UPDRS and Quality of Life: A large multicenter study of 3206 patients (2018 · Parkinsonism & Related Disorders · 被引 82)
• What Effects Might Exenatide have on Non-Motor Symptoms in Parkinson’s Disease: A Post Hoc Analysis (2018 · Journal of Parkinson s Disease · 被引 79)